SOCS5 and allergic asthma: In an allergic asthma model, high levels of SOCS5 in transgenic mice resulted in increased Th2 responses and eosinophilic inflammation, suggesting that SOCS5 overexpression in Th2-dominated diseases is not a useful therapeutic target [124].